Literature DB >> 11056237

Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment.

M M Biljan1, L Lapensée, N G Mahutte, F Bissonnette, R Hemmings, S L Tan.   

Abstract

OBJECTIVE: To investigate the impact of functional ovarian cysts on the time required to achieve pituitary suppression, follicular development, embryo quality, and pregnancy rates during IVF treatment.
DESIGN: Prospective observational study. INTERVENTION(S): Daily treatment with buserelin (sc 500 microg) was initiated on day 2 of menstruation. Ultrasound and hormonal tests were performed on days 1, 7, 11, 14, and weekly thereafter until pituitary suppression was achieved. RESULT(S): 48 patients underwent 51 cycles of IVF treatment. A functional cyst was detected in three cycles (5.8%) with baseline ultrasound scan and in 27 cycles (52.9%) on day 7 of buserelin administration. Patients who developed a cyst required a significantly longer time to achieve pituitary suppression (21 vs. 7 days), had a significantly lower FSH level at the time of initiation of gonadotropins, required more ampules of gonadotropin (45 vs. 41 ampules), developed less follicles (13 vs. 17.5), and had lower embryo quality. However, there were no differences in the implantation (23.5% vs. 17.2%) and pregnancy rates (37.2% vs. 29.2%) between two groups. CONCLUSION(S): Functional cysts prolong the period to achieving pituitary suppression, increase gonadotropin requirements, and decrease follicular recruitment and embryo quality. They have, however, no negative effect on pregnancy rates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056237     DOI: 10.1016/s0015-0282(00)01555-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study.

Authors:  Hong Zeng; Chen Zhang; Lei Zhang; Nenghui Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

2.  Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.

Authors:  Hui Ji; Yan Su; Mianqiu Zhang; Xin Li; Xiuling Li; Hui Ding; Li Dong; Shanren Cao; Chun Zhao; Junqiang Zhang; Rong Shen; Xiufeng Ling
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

3.  Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles.

Authors:  Ozlem Gün Eryılmaz; Esma Sarıkaya; Fatma Nur Aksakal; Sevtap Hamdemir; Muammer Doǧan; Leyla Mollamahmutoǧlu
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.